17 April 2024 - International regulators have published a report today presenting the outcomes of a workshop on COVID-19 vaccine ...
29 February 2024 - The Australian Government has accepted the latest advice from the Australian Technical Advisory Group on Immunisation ...
18 December 2023 - The manufacturer Novavax is no longer pursuing marketing authorisation for its COVID-19 vaccine in Switzerland. ...
19 December 2023 - On the last day of November Texas launched extraordinary legal proceedings that could have wide-ranging political ...
1 December 2023 - The European Medicines Regulatory Network has been at the forefront of the fight against COVID-19 with ...
20 November 2023 - Recommendations from the Australian Technical Advisory Group on Immunisation on the use of XBB 1.5 COVID-19 vaccines. ...
20 November 2023 - The Australian Government has accepted the latest advice from the Australian Technical Advisory Group on Immunisation on ...
31 October 2023 - The EMA’s CHMP has recommended authorising an adapted Nuvaxovid vaccine targeting the Omicron XBB.1.5 subvariant of ...
20 October 2023 - A statement from Australia's Chief Medical Officer, Professor Paul Kelly, on the end of the COVID-19 emergency ...
16 October 2023 - European Union regulators have delayed a decision to give approval for Novavax's variant-tailored COVID-19 vaccine, the ...
3 October 2023 - Today, the US FDA amended the emergency use authorisation of the Novavax COVID-19 vaccine, adjuvanted for use ...
28 September 2023 - Spikevax XBB.1.5 approved for persons aged 18 and over ...
28 September 2023 - The updated vaccine is expected to be available in Canada in the coming weeks. ...
20 September 2023 - It has been just over a week since the US FDA and the US Centers for ...
14 September 2023 - EMA’s human medicines committee (CHMP) has recommended authorising an adapted Spikevax vaccine targeting the Omicron XBB.1.5 ...